Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. - Wikidata - awgldk - TriplyDB

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

http://www.wikidata.org/entity/Q42021046

about

Progress in treatment of ANCA-associated vasculitis Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy: Is Simultaneous Systemic Lupus Erythematosus Associated With Clinical Manifestations?: A Case Report and Review of the Literature Interstitial Lung Disease with ANCA-associated Vasculitis Clinical studies of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis The immunopathology of ANCA-associated vasculitis Genetically distinct subsets within ANCA-associated vasculitis Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.Lung involvement in childhood onset granulomatosis with polyangiitis.Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis.ANCA-associated vasculitis in childhood: recent advances.M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study HMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactions Positivity to p-ANCA in patients with status epilepticus.Microscopic polyangiitis.Diagnosis and treatment of cerebral vasculitis.Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis.Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis Microscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report.Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.A Fulminant Case of Granulomatosis with Polyangiitis with Meningeal and Parenchymal Involvement.Linking classification and therapeutic management of vasculitides.Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis Outcome and treatment of elderly patients with ANCA-associated vasculitis.Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study

P2860

Q21195258-53019D93-3E30-4375-ABCB-8BBF999F2E47 Q26751357-B9C0EE6E-0080-4E41-9FD9-1EEB698A8E4B Q26777537-BB7B226A-A1DA-4F75-B4C6-E682E9F31302 Q26786104-E9D9411D-D35B-401A-9808-F20813A350FB Q26853176-2A458A85-6BA4-43C1-AAC8-01AA770C56EC Q28069646-35F24A72-7EA2-4AC7-AFA4-3ADCABC85141 Q28387801-6A4E7370-8F07-485C-AA53-C0B5A3C08714 Q28389271-1F77D495-6981-4E17-B7A9-93A162E86033 Q28391531-56EA0AB1-6748-457D-B5AD-579598E28350 Q28943363-8319DFAE-C34E-4FD7-B721-930624313A3C Q33411491-90C90C96-6293-4C47-9447-F2ED70D016FF Q33564565-CDEDE143-E5CF-4D0E-B7E8-9646849D1607 Q33590579-B0D2AB18-7038-4B5B-830F-4764CD4BAA73 Q33595396-054E1595-C6E6-452F-A051-907D4F174B20 Q33644574-DBD69827-A38E-4259-9991-FECEF600A992 Q33706866-E5858F2A-C3BC-4E1F-AFB1-D5F862D045F1 Q33767030-DCD0CF28-A9C6-47D2-A15C-C1A8BC200048 Q33844590-87708964-F8C8-49B2-A96C-193879F418A4 Q33957544-D7FA5C8F-7F7E-4537-9C07-37BB6AAE1B71 Q34051500-2AC92E77-F240-425D-9CB4-AE423AD42752 Q34156332-23BC7972-8C61-4595-ABA6-AC8F871C4CEA Q34189483-6B463690-AF83-4956-B16A-A2AE0563DDDB Q34491280-7151A446-76A7-412D-9414-03F579A9D984 Q34604587-1C5C3396-C1BF-4E08-BCB6-8748BE1B7FB6 Q34774851-10946D7C-61E1-4331-90E7-E0105CF21E67 Q34903570-B4D477BF-6A1F-41BA-9F5E-459966C5BB61 Q35124231-CA7D658C-AF0F-4E66-B31B-81DC1F85C287 Q35157297-AC1DBE50-F378-4A3B-9D26-0CBF26151772 Q35158943-DC09173A-6C00-4188-9F08-4B38348BE153 Q35662632-D378186F-8FCA-4181-9200-2D1D0EF5488C Q35672892-4E3463D6-664B-4CCA-9969-4A4DFAEAAD0F Q35724221-E895A790-0CA5-44AE-9F5B-66DCE69E56E8 Q35759180-A521B291-8289-4CD0-9EB5-FA29A21E3673 Q35816989-86D40F2E-FF20-4A1A-8507-F7C401B1C4A1 Q35851713-A33FB44E-20E7-4858-BE37-ECFA8F1D01A4 Q35900660-8E37E34E-A732-4D02-A710-22188248C8F3 Q35946777-E52109EC-AC98-49BD-8D23-C261D0E2BBA4 Q35996558-4EE1CDCA-9CBB-41C9-BD67-0A56B3D40900 Q35998297-56651B97-FF21-4B70-B85D-A5E8E0BCBC05 Q36014017-DEAECA04-44A7-4E7E-857B-EEB1375D91C3

P2860

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

http://www.wikidata.org/entity/Q42021046

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Development and validation of ...... a for epidemiological studies.

@en

Development and validation of ...... a for epidemiological studies.

@nl

type

label

Development and validation of ...... a for epidemiological studies.

@en

Development and validation of ...... a for epidemiological studies.

@nl

prefLabel

Development and validation of ...... a for epidemiological studies.

@en

Development and validation of ...... a for epidemiological studies.

@nl

P1433

Q42021046-4EBC0429-7DD0-4281-8D94-A0CA225B012D

P1476

Q42021046-AABBF88D-704B-43DF-91BF-1A3BEF38E408

P2093

Q42021046-2CD7468F-C58E-4DBB-9B1C-72D095EBB5AA

Q42021046-67A4AE16-749F-417A-A247-464D18FCF447

Q42021046-6EA80305-F923-4A44-A176-0F1B8FBCB45C

Q42021046-7DEB5457-6CD6-455F-8C1B-B156E4347E17

Q42021046-8D9F2935-D956-42B8-9BAF-C1867E768FC7

Q42021046-C238E9EC-6A0F-4C59-A7B7-1B38A55F98CD

Q42021046-E309F23A-F432-432F-A4D2-AF89654AAD16

Q42021046-F96689BB-0955-4334-9366-7177309329AB

P2860

Q42021046-354DCA53-3C63-4B24-9F6E-F57DBA35C1ED

Q42021046-385B693C-4E3A-4EBE-A9C2-80748A483976

Q42021046-3A50D630-EA43-4657-85E4-35E870DC3D3F

Q42021046-441FEE1F-2C9D-4E83-9C53-93F5A3C16736

Q42021046-45DD879F-09BC-455C-8804-93532A6D097E

Q42021046-640AEEC9-37F5-43FD-B0DF-46B79A9316E3

Q42021046-8A0434EC-7FB6-42F7-B31B-BB71C8383C4B

Q42021046-9526CC91-0379-43D0-834D-1866C1C37EBE

Q42021046-9CCBF68D-817B-4CB0-9395-A3F7ACADD7AC

Q42021046-AC0D41A8-4B61-4141-8849-066AE4847333

P304

Q42021046-070AB976-5E91-4826-969B-EEDA7DD712C0

P31

Q42021046-9B1A6DF5-6F84-4FE3-9645-376826AF0DC7

P356

Q42021046-05BAA8BD-37A7-4FFC-BF64-3B6DF5A840AD

P407

Q42021046-F630C4E5-C70D-4E20-8532-5780BB2304B6

P433

Q42021046-677CE54B-5D3D-4BC3-AB08-BD202D9879CF

P478

Q42021046-F95F23A4-915E-49A6-8025-D907B9A9386D

P50

Q42021046-ECD85EA3-CB1E-41C5-867C-FA5E4AD6365A

Q42021046-F4767357-C207-43E1-AA79-816211666032

P577

Q42021046-58B7DC6B-B79C-466F-BE77-50C4CBDF90C0

P5875

Q42021046-59615CF6-40E0-406C-B291-0107E30768EA

P698

Q42021046-FE295701-376A-4172-8EBD-28893D18EFBF

P921

Q42021046-1938852B-00C8-4384-A365-1558CA893106

P932

Q42021046-615534F1-EB17-4157-8A07-688987ABBEB8

P356

ARD.2006.054593

P1433

Annals of the Rheumatic Diseases

P1476

Development and validation of ...... sa for epidemiological studies

@en

P2093

Bernhard Hellmich

http://www.w3.org/2001/XMLSchema#string

David Scott

http://www.w3.org/2001/XMLSchema#string

Jan W Cohen-Tervaert

http://www.w3.org/2001/XMLSchema#string

Richard Watts

http://www.w3.org/2001/XMLSchema#string

Suzanne Lane

http://www.w3.org/2001/XMLSchema#string

Thomas Hanslik

http://www.w3.org/2001/XMLSchema#string

Thomas Hauser

http://www.w3.org/2001/XMLSchema#string

Wenche Koldingsnes

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients.

Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.

Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Epidemiology of vasculitis in Europe.

The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary.

P304

222-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2006.054593

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Mårten Segelmark

P577

2006-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6885288

http://www.w3.org/2001/XMLSchema#string

P698

16901958

http://www.w3.org/2001/XMLSchema#string

P921

P932

1798520

http://www.w3.org/2001/XMLSchema#string